Related Experiment Video
Updated: Dec 23, 2025

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
The positive feedback loop between Nrf2 and phosphogluconate dehydrogenase stimulates proliferation and clonogenicity
Athena Jessica Ong1, Soma Saeidi1,2, Ngo Hoang Kieu Chi1
1Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea.
Abstract:
Recent studies report that nuclear factor-erythroid-2-related factor 2 (Nrf2) facilitates tumor progression through metabolic reprogramming in cancer cells. However, the molecular mechanism underlying the oncogenic functions of Nrf2 is not yet well understood. Some of the pentose phosphate pathway (PPP) enzymes are considered to play a role in the cancer progression. The present study was intended to explore the potential role of phosphogluconate dehydrogenase (PGD), one of the PPP enzymes, in the proliferation and migration of human hepatoma HepG2 cells. Genetic ablation of Nrf2 attenuated the expression of PGD at both transcriptional and translational levels. Notably, Nrf2 regulates the transcription of PGD through direct binding to the antioxidant response element in its promoter region. Nrf2 overexpression in HepG2 cells led to increased proliferation, survival, and migration, and these events were suppressed by silencing PGD. Interestingly, knockdown of the gene encoding this enzyme not only attenuated the proliferation and clonogenicity of HepG2 cells but also downregulated the expression of Nrf2. Thus, there seems to exist a positive feedback loop between Nrf2 and PGD which is exploited by hepatoma cells for their proliferation and survival. Treatment of HepG2 cells with ribulose-5-phosphate, a catalytic product of PGD, gave rise to a concentration-dependent upregulation of Nrf2. Collectively, the current study shows that Nrf2 promotes hepatoma cell growth and progression, partly through induction of PGD transcription.
Insights
Nuclear factor-erythroid-2-related factor 2 (Nrf2) drives cancer growth by increasing phosphogluconate dehydrogenase (PGD). This study reveals a positive feedback loop between Nrf2 and PGD in hepatoma cells, crucial for their proliferation and survival.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Nuclear factor-erythroid-2-related factor 2 (Nrf2) is implicated in cancer progression via metabolic reprogramming.
- The precise molecular mechanisms of Nrf2's oncogenic functions remain unclear.
- Pentose phosphate pathway (PPP) enzymes are increasingly recognized for their role in cancer progression.
Purpose of the Study:
- To investigate the role of phosphogluconate dehydrogenase (PGD), a PPP enzyme, in the proliferation and migration of human hepatoma HepG2 cells.
- To elucidate the regulatory relationship between Nrf2 and PGD in hepatoma cells.
Main Methods:
- Genetic manipulation of Nrf2 and PGD expression in HepG2 cells (gene ablation, overexpression, knockdown).
- Analysis of gene and protein expression levels.
- Assessment of cell proliferation, survival, migration, and clonogenicity.
- Reporter assays to confirm transcriptional regulation via antioxidant response element (ARE).
Main Results:
- Nrf2 genetic ablation reduced PGD expression at transcriptional and translational levels.
- Nrf2 directly binds to the ARE in the PGD promoter, regulating its transcription.
- Nrf2 overexpression enhanced HepG2 cell proliferation, survival, and migration, effects reversed by PGD silencing.
- PGD knockdown inhibited HepG2 cell proliferation and clonogenicity and downregulated Nrf2 expression.
- A positive feedback loop between Nrf2 and PGD was identified, promoting hepatoma cell growth.
- Ribulose-5-phosphate treatment upregulated Nrf2 in a concentration-dependent manner.
Conclusions:
- Nrf2 promotes hepatoma cell growth and progression, partly by inducing PGD transcription.
- A positive feedback loop exists between Nrf2 and PGD, essential for hepatoma cell proliferation and survival.
- Targeting the Nrf2-PGD axis may offer therapeutic strategies for hepatoma treatment.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cell Signaling Feedback Loops
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
TGF - β Signaling Pathway

